India's Push for API Self-Reliance Under the PLI Scheme
India’s Production Linked Incentive (PLI) scheme for bulk drugs and key starting materials is transforming the country’s pharmaceutical manufacturing landscape, pushing the sector toward self-reliance.
Production Linked Incentive (PLI) Scheme | 31/08/2025 | By Darshana | 402
Piyush Goyal Calls on Medtech Industry to Invest Heavily in Domestic Manufacturing and R&D
Union Minister of Commerce and Industry, Piyush Goyal, has urged the MedTech industry to shift from being a market for imported goods to becoming a global manufacturing and innovation hub.
Production Linked Incentive (PLI) Scheme | 29/08/2025 | By Dineshwori
India's Pharma Exports Surge 92 Percent in Six Years: Anupriya Patel
Driven by various government schemes, India’s drug and pharmaceutical exports have risen from INR 1,28,028 crore in FY2018-19 to INR 2,45,962 crore in FY2024-25.
Production Linked Incentive (PLI) Scheme | 26/07/2025 | By Dineshwori | 148
India Clears 48 Projects Under PLI Scheme to Boost Domestic Production of Key Drug Ingredients
A total of 48 projects have been approved under the Production Linked Incentive (PLI) Scheme to boost domestic manufacturing of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs) in India, according to the Ministry of Chemicals and Fertilizers.
Production Linked Incentive (PLI) Scheme | 23/07/2025 | By Dineshwori | 175
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy